» Articles » PMID: 29997535

Non-medical Cannabis Self-Exposure As a Dimensional Predictor of Opioid Dependence Diagnosis: A Propensity Score Matched Analysis

Overview
Specialty Psychiatry
Date 2018 Jul 13
PMID 29997535
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The impact of increasing non-medical cannabis use on vulnerability to develop opioid use disorders has received considerable attention, with contrasting findings. A dimensional analysis of self-exposure to cannabis and other drugs, in individuals with and without opioid dependence (OD) diagnoses, may clarify this issue. To examine the age of onset of maximal self-exposure to cannabis, alcohol, cocaine, and heroin, in volunteers diagnosed with OD, using a rapidly administered instrument (the KMSK scales). To then determine whether maximal self-exposure to cannabis, alcohol, and cocaine is a dimensional predictor of odds of OD diagnoses. This outpatient observational study examined maximal self-exposure to these drugs, in volunteers diagnosed with DSM-IV OD or other drug diagnoses, and normal volunteers. In order to focus more directly on opioid dependence diagnosis as the outcome, volunteers who had cocaine dependence diagnoses were excluded. Male and female adults of diverse ethnicity were consecutively ascertained from the community, and from local drug treatment programs, in 2002-2013 ( = 574, of whom = 94 had OD diagnoses). The age of onset of maximal self-exposure of these drugs was examined. After propensity score matching for age at ascertainment, gender, and ethnicity, a multiple logistic regression examined how increasing self-exposure to non-medical cannabis, alcohol and cocaine affected odds of OD diagnoses. Volunteers with OD diagnoses had the onset of heaviest use of cannabis in the approximate transition between adolescence and adulthood (mean age = 18.9 years), and onset of heaviest use of alcohol soon thereafter (mean age = 20.1 years). Onset of heaviest use of heroin and cocaine was detected later in the lifespan (mean ages = 24.7 and 25.3 years, respectively). After propensity score matching for demographic variables, we found that the maximal self-exposure to cannabis and cocaine, but not to alcohol, was greater in volunteers with OD diagnoses, than in those without this diagnosis. Also, a multiple logistic regression detected that increasing self-exposure to cannabis and cocaine, but not alcohol, was a positive predictor of OD diagnosis. Increasing self-exposure to non-medical cannabis, as measured with a rapid dimensional instrument, was a predictor of greater odds of opioid dependence diagnosis, in propensity score-matched samples.

Citing Articles

Opioids and Youth Athletes.

Benjamin H, Perri M, Leemputte J, Lewallen L, DeVries C Sports Health. 2024; 16(2):269-278.

PMID: 38366642 PMC: 10916775. DOI: 10.1177/19417381241228629.


Longitudinal associations between age 20 problematic substance use and opioid use disorder incidence at age 30 - findings from an urban cohort.

Thrul J, Rabinowitz J, Reboussin B, Maher B, Anthony J, Ialongo N J Psychiatr Res. 2023; 160:1-7.

PMID: 36764195 PMC: 10023426. DOI: 10.1016/j.jpsychires.2023.01.033.


Acute Delta 9-tetrahydrocannabinol administration differentially alters the hippocampal opioid system in adult female and male rats.

Windisch K, Mazid S, Johnson M, Ashirova E, Zhou Y, Gergoire L Synapse. 2021; 75(10):e22218.

PMID: 34255372 PMC: 8390442. DOI: 10.1002/syn.22218.


Age of onset of heaviest use of cannabis or alcohol in persons with severe opioid or cocaine use disorders.

Butelman E, Chen C, Brown K, Lake K, Kreek M Drug Alcohol Depend. 2021; 226:108834.

PMID: 34216857 PMC: 11851329. DOI: 10.1016/j.drugalcdep.2021.108834.


Bidirectional influence of heroin and cocaine escalation in persons with dual opioid and cocaine dependence diagnoses.

Butelman E, Chen C, Lake K, Brown K, Kreek M Exp Clin Psychopharmacol. 2020; 30(1):31-38.

PMID: 33119382 PMC: 8388238. DOI: 10.1037/pha0000401.


References
1.
Mayet A, Legleye S, Falissard B, Chau N . Cannabis use stages as predictors of subsequent initiation with other illicit drugs among French adolescents: use of a multi-state model. Addict Behav. 2011; 37(2):160-6. DOI: 10.1016/j.addbeh.2011.09.012. View

2.
Hernandez-Avila C, Rounsaville B, Kranzler H . Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend. 2004; 74(3):265-72. DOI: 10.1016/j.drugalcdep.2004.02.001. View

3.
Hall W, West R, Marsden J, Humphreys K, Neale J, Petry N . It is premature to expand access to medicinal cannabis in hopes of solving the US opioid crisis. Addiction. 2018; 113(6):987-988. DOI: 10.1111/add.14139. View

4.
Bond C, LaForge K, Tian M, Melia D, Zhang S, Borg L . Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A. 1998; 95(16):9608-13. PMC: 21386. DOI: 10.1073/pnas.95.16.9608. View

5.
Hill K . Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders. JAMA. 2017; 317(10):1070-1071. DOI: 10.1001/jama.2016.19706. View